Skip to content

Co-operative surgical trial for gastric cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13882846
Enrollment
400
Registered
2001-02-28
Start date
1986-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Cancer Gastric cancer

Interventions

Arm 1: conventional (R1) resection of tumour. Arm 2: radical (R2) resection of tumour.

Sponsors

Medical Research Council (MRC) (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Histologically or cytologically proven invasive gastric adenocarcinoma (stage I-III).

Exclusion criteria

Exclusion criteria: The patient must not have a perforated gastric carcinoma requiring emergency surgery.

Design outcomes

Primary

MeasureTime frame
1. Operative morbidity and mortality (within 6 weeks of surgery) 2. Post-operative sequelae 3. Survival - with and without evidence of cancer 4. Local recurrence 5. Site and distribution of metastatic disease

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026